Investigation

Veritone Reports Fourth Quarter and Fiscal Year 2023 Results

Retrieved on: 
Tuesday, March 12, 2024

Financial Results for Three Months Ended December 31, 2023

Key Points: 
  • Financial Results for Three Months Ended December 31, 2023
    Delivered fourth quarter revenue of $34.2 million, a decrease of $9.7 million or 22.1% from $43.9 million in the fourth quarter of 2022.
  • Financial Results Full Year Ended December 31, 2023
    Delivered fiscal year 2023 revenue of $127.6 million, a decrease of $22.2 million or 14.8% year over year.
  • Revenue is expected to be in the range of $134.0 million to $142.0 million, as compared to $127.6 million for fiscal 2023.
  • Non-GAAP net loss is expected to be in the range of $11.0 million to $15.0 million, compared to non-GAAP net loss of $37.5 million for fiscal 2023.

CBSA firearms investigation leads to prison time for Keswick man

Retrieved on: 
Wednesday, April 3, 2024

MISSISSAUGA, ON, April 3, 2024 /CNW/ - The Canada Border Services Agency (CBSA) is committed to keeping prohibited firearms and firearms parts from entering Canada and ensuring anyone who breaks Canada's laws is held accountable.

Key Points: 
  • MISSISSAUGA, ON, April 3, 2024 /CNW/ - The Canada Border Services Agency (CBSA) is committed to keeping prohibited firearms and firearms parts from entering Canada and ensuring anyone who breaks Canada's laws is held accountable.
  • On March 15, Michael Vukmanovic of Keswick, Ontario was sentenced to 11 years in prison after pleading guilty to 16 charges under the Criminal Code for firearms manufacturing and possession.
  • This sentence is the result of an investigation led by the CBSA's Intelligence and Investigations Operations Divisions in Toronto following a firearm seizure in Southern Ontario.
  • The CBSA launched its investigation in January 2022 when Border Services Officers in Windsor, Ontario intercepted firearm parts in courier parcels destined for Vukmanovic's residence in Keswick.

ROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI

Retrieved on: 
Monday, March 11, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, March 9, 2024

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • For more information on the Chemours investigation go to: https://bespc.com/cases/CC
    On February 20, 2024, Methanex issued a press release “announc[ing] .
  • The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”).
  • For more information on the Inari Medical investigation go to: https://bespc.com/cases/NARI

NARI INVESTOR NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI

Retrieved on: 
Tuesday, March 5, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI

Retrieved on: 
Saturday, March 2, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

INARI MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inari Medical, Inc. on Behalf of Inari Medical Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, March 1, 2024

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inari Medical, Inc. (“Inari Medical” or the “Company”) (NASDAQ: NARI) on behalf of Inari Medical stockholders.

Key Points: 
  • NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inari Medical, Inc. (“Inari Medical” or the “Company”) (NASDAQ: NARI) on behalf of Inari Medical stockholders.
  • Our investigation concerns whether Inari Medical has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”).

Blank Rome Adds Leading White Collar Team, Continuing Nationwide Expansion

Retrieved on: 
Monday, February 26, 2024

The group’s arrival continues the strategic expansion of Blank Rome’s White Collar Defense and Investigations group.

Key Points: 
  • The group’s arrival continues the strategic expansion of Blank Rome’s White Collar Defense and Investigations group.
  • In January, five white collar attorneys from litigation boutique Spears & Imes joined Blank Rome in New York, including partners David Spears , Linda Imes , and Chris Dysard .
  • In November 2023, Barrett R. Howell joined the White Collar Defense and Investigations group as a partner in the firm’s recently opened Dallas office.
  • They focus on white collar defense litigation, government investigations and enforcement actions, international disputes and arbitration, internal investigations, and advising clients on compliance programs, voluntary disclosures, and remediation.

Tingo Group, Inc. to File Form 25 to Voluntarily Delist its Common Stock from the Nasdaq Stock Market

Retrieved on: 
Tuesday, February 20, 2024

MONTVALE, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”) today announced that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Stock Market (“Nasdaq”).

Key Points: 
  • MONTVALE, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”) today announced that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Stock Market (“Nasdaq”).
  • The Company’s audit committee reduced to two members on December 20, 2023, following the resignation of Mr. Jamal Khurshid.
  • Having carefully considered the above non-compliance matters together with other factors, and consulted with Nasdaq, the Company’s Board of Directors (the “Board”) has decided it is in shareholders’ best interests to file Form 25 and voluntarily delist from Nasdaq.
  • Once the investigation has been completed, and any appropriate actions taken, the Company will consider reapplying for a listing on Nasdaq or another major stock exchange.

Former Federal Prosecutor Seth Goertz Joins Dorsey in Phoenix

Retrieved on: 
Tuesday, March 5, 2024

Dorsey & Whitney LLP continues the expansion of the Phoenix office and its nationally recognized Government Solutions & Investigations group with the arrival of former federal prosecutor Seth Goertz , the law firm announced today.

Key Points: 
  • Dorsey & Whitney LLP continues the expansion of the Phoenix office and its nationally recognized Government Solutions & Investigations group with the arrival of former federal prosecutor Seth Goertz , the law firm announced today.
  • View the full release here: https://www.businesswire.com/news/home/20240305604950/en/
    Dorsey & Whitney LLP continues the expansion of the Phoenix office and its nationally recognized Government Solutions & Investigations group with the arrival of former federal prosecutor Seth Goertz.
  • “We are excited to welcome Seth to our Phoenix office.
  • Seth advances the strategic growth of the firm’s Government Solutions & Investigations team by adding white-collar defense and government investigation capabilities in Phoenix.